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Alteration of Extracellular pH Dependence of CLC-5 By Modifications
of Two Conserved Charged Residues
Giovanni Zifarelli, Michael Pusch.
Istituto di Biofisica, Genoa, Italy.
The endosomal Cl(-) / H(þ) antiporter, ClC-5, is inhibited by low extracellular
pH. This could be caused by the saturation of a titratable residue which is di-
rectly involved in proton translocation towards the extracellular solution; alter-
natively, the reduction of currents at low pH could reflect an unspecific electro-
static effect of some titratable residue on proton and / or chloride movement
within the external vestibule. To gain insight into the mechanism of the pH de-
pendence we investigated the possible involvement of two highly conserved
charged residues (D76 and K210) which are located in the extracellular vesti-
bule. Mutants D76G and D76H drastically altered pH dependence. Preliminary
experiments indicated that also K210C slightly altered the pH dependence. In-
terestingly, the K210C mutant could be modified by pCMBS (p-chloromercur-
iphenylsulfonic acid): application of 100 mM pCMBS led to a partial and irre-
versible inhibition of K210C mediated currents (but not WT ClC-5 currents).
Our results favor the idea that neither D76 nor K210 are directly involved in
proton translocation. However, further experiments, exploiting the possibility
to modify K210C with various cysteine modifying reagents, are necessary to
draw such a firm conclusion.
1663-Pos
Role of the Q-R Linker in Hþ/Cl- Coupling in a CLC Exchanger
Christopher Hills, Sophie Bruce, Alessio Accardi.
University of Iowa, Iowa City, IA, USA.
Members of the CLC family function as Cl- channels or as Hþ/Cl- exchangers.
Despite this mechanistic divide the two CLC sub-classes share many functional
and structural traits. CLC-ec1, a transporter, can be transformed into a Cl--se-
lective pore by simultaneously removing the intra- and extra-cellular gates.
This entailed mutating two residues, E148 and Y445, which are conserved in
both CLC channels and transporters. While the extracellular gate regulates
channel gating, the intracellular one does not. We hypothesized that in the
channels the intracellular gate’s position is shifted so that it does not regulate
ion passage anymore.
The linker connecting helices R and Q is 1-2 amino-acids shorter in the chan-
nels than in the transporters. We investigated whether shortening this linker dis-
rupts the intracellular gate of CLC-ec1 while preserving Y445. To this end we
deleted two residues, G441 and K442, in the Q-R linker. This deletion, DGK,
functionally mirrors the gate-removed Y445A mutant: Hþ transport is nearly
abolished with slight effects on Cl- transport. We then tested the effects of sin-
gle-residue deletions. The DG mutant is similar to the WT while the DK dele-
tion impairs Hþ transport like the DGK deletion. K442 however is not involved
in Hþ transport: Alanine or Methionine substitutions have no significant ef-
fects.
Lastly, we incorporated in CLC-ec1 increasing portions of the CLC-0 channel.
Introduction of the CLC-0 Q-R linker into CLC-ec1 recapitulates the functional
effects of the DGK and DK mutations. Introduction into CLC-ec1 of up to the
full helix R from CLC-0 led to no further effects on Hþ transport.
In conclusion we found that the length of the Q-R linker is critical for Hþ/Cl-
coupling in CLC-ec1 while the chemical properties of the residues in the linker
do not seem to matter.
1664-Pos
Proton Block of Human CLC-5 Cl-/Hþ Exchanger
Alessandra Picollo, Mattia Malvezzi, Alessio Accardi.
University of Iowa, Iowa City, IA, USA.
CLC-5 is a human Cl-/Hþ exchanger of the CLC family. It is expressed in in-
tracellular compartments such as endosomes, where it regulates their acidifica-
tion and is indirectly involved in the re-uptake of small molecular weight pro-
teins in renal proximal tubule. Mutations in the CLC-5 gene lead to Dent’s
disease, a human disorder characterized by low molecular-mass proteinuria,
kidney stones and renal failure. CLC-5 currents are strongly outwardly rectify-
ing suggesting that the rates in the transport cycle are highly asymmetrical so
that Cl- influx and Hþ efflux is permitted while the converse is not. Additionally
CLC-5 currents are strongly inhibited by low external pH. It has been proposed
that the rectification arises from the voltage dependence of a Hþ transport step
and that the pH dependence is a result of a reduction in the total driving force
for turnover. We studied the extracellular pH dependence of CLC-5 currents
between pH 9 and 4.5. We found that the pH dependence is not solely due to
changes in the driving force. Rather, we found that the degree of current inhi-
bition is voltage dependent: at less positive potentials Hþ inhibition becomes
stronger. This is consistent with a direct modulation of CLC-5 activity by
Hþ at a single site located ~70% deep into the electric field. We propose thatthis site is E211, the extracellular gating glutamate. In the presence of extracel-
lular SCN- Hþ transport is abolished but both rectification and Hþ inhibition
remain largely unaltered. This suggests that Hþ transport determines neither
the pH dependence nor rectification. We propose that the extracellular pH in-
hibition of CLC-5 currents arises from Hþ trying to drive the transport cycle
in the non-permissive direction. In other words, inhibition of the CLC-5 cur-
rents by extracellular Hþ is a consequence of its rectification.
1665-Pos
A Monomeric Variant of the CLC-ec1 Transporter
Janice L. Robertson, Ludmila Kolmakova-Partensky, Christopher Miller.
HHMI/Brandeis University, Waltham, MA, USA.
CLC-ec1, a prototypical Cl-/Hþ exchanger of the CLC family, is a homodimer
in which each subunit is thought to act as a fully functional transporter. Why
then is this protein a dimer and what are the factors driving dimer formation?
In this study, we address these questions by destabilizing the CLC-ec1 subunit-
subunit interface. We substituted tryptophan residues to create steric mis-
matches at the interface that would also favor lipid interactions. A single mu-
tation, I422W, was sufficient to destabilize the CLC-ec1 complex resulting in
a shift from dimer to monomer position on gel-filtration chromatography. Glu-
taraldehyde cross-linking of I422W in both detergent and phosphatidyl-cho-
line/phosphatidyl-glycerol liposomes showed that the mutant remained a mono-
mer compared to the wild-type protein; however dimer formation was
observable at high concentrations. The I422W mutant was functional as mea-
sured by 36Cl- uptake, passive Cl- efflux and Cl- driven Hþ pumping in E.
coli phospholipids. A Poisson-counting method demonstrated that I422W re-di-
merizes in these phosphatidyl-ethanolamine-rich liposomes, even at very low
protein/lipid ratio. Altogether, these findings suggest that we have purified an
isolated monomeric variant of CLC-ec1 that demonstrates shifted dimerization
energetics depending on the lipid environment. We continue to search for mu-
tations that will more severely destabilize the dimer, in attempts to obtain
a transport-competent, monomeric CLC exchanger.
1666-Pos
Analysis of the CLC-1 ATP Binding Site by Structure-GuidedMutagenesis
Pang-Yen Tseng, Tsung-Yu Chen.
Center for Neuroscience, University of California, Davis, Davis, CA, USA.
The CLC-1 chloride channel is abundantly expressed on the cell membrane of
skeletal muscles, and thus plays an important role in controlling the muscle ex-
citability. We previously showed that ATP can modulate the common gating of
CLC-1, presumably by binding to a potential binding site at the C-terminal cy-
toplasmic region of the channel. The X-ray crystallographic study by others re-
vealed the structure of the ATP-binding site, and two residues, Y617 and D727,
were identified to be important for the ATP binding. Based on the CLC-5 C-ter-
minal structure, we identify that besides V634 and E865 of CLC-1 (correspond-
ing to Y617 and D727 of CLC-5), V613 and E860 are also important for the
ATP modulation of the CLC-1 common gating. Mutating V634 to either ala-
nine or aspartate abolishes the ATP modulation effect. Surprisingly, mutations
of V634 to aromatic amino acids increase the ATP affinity: V634F and V634Y
mutations decrease the apparent K1/2 by ~30- and ~13-fold, respectively. Mu-
tations of E865 to alanine and serine abolish the ATP modulation, while
a charge-conserved mutation, E865D, greatly decreases the efficacy of the
ATP effect_the maximal shift of the V1/2 of the common gate P-V curve is
~10-20 % of that in the WT channel. Mutations of V860 and V613 to various
amino acids also greatly reduce the efficacy of the ATP modulation. Double
mutant cycle analyses show that V634 and V613 are strongly energetically cou-
pled, with a coupling coefficient (U) of ~25, while V634 and E865 may be only
weakly coupled with a U value of ~1.6. These results support the idea that ATP
likely binds directly to the C-terminus of CLC-1 to modulate the common gat-
ing of the channel.
1667-Pos
Substrate-Driven Conformational Changes in CLC-ec1 Observed by
Fluorine NMR
Shelley Elvington, Corey Liu, Merritt Maduke.
Stanford University, Stanford, CA, USA.
The CLC ‘‘Cl- channel’’ family consists of both Cl-/Hþ antiporters and Cl-
channels. This scenario presents a unique opportunity to investigate the molec-
ular similarities and differences underlying these mechanisms. Although gating
in CLC channels is known to involve large, cooperative conformational
changes between protein subunits, it has been hypothesized that conformational
changes in the antiporters may be confined to small movements localized near
the Cl- permeation pathway. However, to date few studies have directly ad-
dressed this issue, and therefore little is known about the molecular movements
that underlie CLC-mediated antiport. The crystal structure of the E. coli anti-
porter ClC-ec1 provides an invaluable molecular framework for such studies,
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cur during ion transport. To address this issue, we have utilized fluorine NMR
to monitor substrate-induced conformational changes in ClC-ec1. We show that
substrate-driven conformational change is not constrained to the Cl- permeation
pathway alone, and that the ClC-ec1 subunit interface participates in protein
movement. Furthermore, removal of the protein’s Hþ transport ability does
not eliminate the Hþ-dependent protein movement observed in the intact anti-
porter. Finally, we observe that a ClC-ec1 ‘‘channel-like’’ mutant is not subject
to the same substrate-dependent conformational changes that occur in the ClC-
ec1 transporters. Together, these results provide new insight into conforma-
tional change in ClC-ec1 and lay an essential foundation for future studies
on ClC-ec1 protein dynamics.
1668-Pos
Cardioprotective Role For the CLC-3 Chloride Channel in the mdxMouse
Model of Duchenne Muscular Dystrophy
Nathanael Heyman, Ryan Wuebbles, Linda Ye, Dayue Duan, Joe Hume,
Dean Burkin.
University of Nevada, Reno, NV, USA.
Duchenne Muscular Dystrophy (DMD) is the most common human X-linked
disease affecting 1/3,500 male births. DMD patients suffer from severe, pro-
gressive muscle wasting with clinical symptoms first detected between 2 to 5
years of age. As the disease progresses patients are confined to a wheelchair
in their early teens and die in their early twenties from cardiopulmonary failure.
There is currently no effective treatment or cure for DMD. DMD patients and
mdx mice (the mouse model for DMD) have mutations in the dystrophin gene
that result in an absence of the dystrophin protein. Dystrophin is a 427 kDa pro-
tein located under the sarcolemma on the inner cytoplasmic membrane of skel-
etal and cardiac muscle cells and provides structural and functional integrity to
muscle. Although therapies have been developed that target skeletal muscle
disease, increasing evidence suggests correcting the cardiomyopathy is critical
to the survival of DMD patients. As the cardiomyopathy progresses, the hearts
of DMD patients and mdx mice exhibit arrhythmias, conduction abnormalities
and left ventricular dilation. Recent studies have shown that the chloride ion
channel ClC-3, a candidate protein responsible for volume-regulated chloride
channels in heart, plays a critical cardioprotective role against the development
of hypertrophy and failure (J Mol. Cell. Cardiol. 2009 Jul 15. [Epub ahead of
print]).Using transgenic mice including heart specific ClC-3 knockout mdx
mice, echocardiography and electrophysiology, we analyzed the role of ClC-
3 in modulating cardiac disease progression in dystrophic mice. Our prelimi-
nary results indicate ClC-3 may be a major modifier of cardiac disease progres-
sion in mdx mice and targeting ClC-3 expression or function may provide
a novel therapeutic approach for the treatment of dilated cardiomyopathy in
DMD (supported by 3P20RR015581 from the National Center for Research
Resources).
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Blocking Kinetics of CFTR Channel by Aromatic Carboxylic Acid
Positional Isomers Characterised using a Novel Amplitude Distribution
Analysis Method
Ying-Chun Yu1,Yoshiro Sohma1,2, Yumi Nakamura1, Tomoka Furukawa1,3,
Yohei Matsuzaki1,4, Seiko Kawano5, Tzyh-Chang Hwang2, Masato Yasui1.
1Dept. of Pharmacology, Keio University School of Medicine, Tokyo, Japan,
2Dalton Cardiovascular Research Center, University of Missouri-Columbia,
Columbia, MO, USA, 3Dept. of Biomolecular Engineering, Tokyo Institute
of Technology, Tokyo, Japan, 4Dept. of Pediatrics, Keio University School of
Medicine, Tokyo, Japan, 5Dept. of Health and Nutrition Sciences, Komazawa
Women’s University Faculty of Human Health, Tokyo, Japan.
To investigate the pore structure of the cystic fibrosis transmembrane conduc-
tance regulator (CFTR) channel, we performed a systematic pore probing on
CFTR channel pore with a series of small aromatic carboxylic acids, including
their positional isomers, e.g., 9-anthracene carboxylic acid (9-AC) and 1-an-
thracene carboxylic acid (1-AC).
Small compounds presumably interacting the channel protein with a few points
are sensitive to structural changes of the binding site. However such low affin-
ity blockers show fast - intermediate blocking kinetics which give us the overall
affinity, but not on- and off- rates separately. To overcome this problem, we de-
veloped an iterative simulation method to estimate the on- and off- rate con-
stants in the 9-AC or 1-AC block from the single channel amplitude distribu-
tion.
The newly developed Amplitude Distribution Analysis (ADA) program first
generated a single-channel current according to the given kinetic scheme and
added a Gaussian noise to the currents for mimicking the background noise.
The simulated currents were low-pass filtered and digitized at the same fre-
quencies as those in the experiments and binned into an amplitude histogram.Then the program repeats a direct likelihood comparison between the simulated
and experimental current amplitude distributions to find the best fitted values
for the blocking kinetic parameters.
The ADA program showed that the off-rate of 1-AC block is 3-fold slower than
that of 9-AC and the on-rate of 1-AC is ~3-fold faster than that of 9-AC. The
voltage-dependences of on- and off- rates of 1-AC are similar to those of 9-AC,
respectively. These suggest that 1-AC and 9-AC block CFTR channel by bind-
ing to a common binding site which should be modeled by a combination of
a positive charge tightly surrounded by hydrophobic residues.
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Effects of Aromatic Carboxylic Acids on Genistein- and Curcumin- Poten-
tiated G551D-CFTR
Yumi Nakamura1, Akiko Hanyuda1, Ying-Chun Yu1, Tomoka Furukawa1,2,
Yohei Matsuzaki1,3, Yoichiro Abe1, Silvia Bompadore4,
Tzyh-Chang Hwang4, Masato Yasui1, Yoshiro Sohma1,4.
1Dept. of Pharmacology, Keio University School of Medicine, Tokyo, Japan,
2Department of Biomolecular Engineering, Tokyo Institute of Technology,
Tokyo, Japan, 3Dept. of Pediatrics, Keio University School of Medicine,
Tokyo, Japan, 4Dalton Cardiovascular Research Center, University of
Missouri-Columbia, Columbia, MO, USA.
The Cystic fibrosis transmembrane conductance regulator (CFTR) chloride
channel plays an important role in salt and water transport across epithelia
and defective function due to mutations in the CFTR gene cause cystic fibrosis
(CF). The glycine-to-aspartate missense mutation at position 551 (G551D) is
the third most common CF-associated mutation and G551D-CFTR is character-
ized by a very low open probability despite of its normal trafficking to the
plasma membrane.
Numerous small molecules have been shown to increase the activity of G551D-
CFTR presumably by binding to the CFTR protein. Among the many G551D-
CFTR potentiators, a bioflavonoid found in legumes, genistein is perhaps the
most extensively studied. More recently it was reported that a component of
the spice turmeric, curcumin strongly activated G551D-CFTR. However, The
mechanism through which these compounds increase G551D-CFTR activity
is still unclear. On the other hand, we have previously reported that anthra-
cene-9-carboxylate (9-AC) showed an inhibitory effect and an potentiation ef-
fect on CFTR channels by binding to two chemically distinct sites for each ef-
fect (Ai et al, 2004).
In this study, we made a functional probing on genistein-potentiated G551D-
CFTR and curcumin-potentiated G551D-CFTR using 9-AC and its positional
isomer, anthracene-1-carboxylate (1-AC). In wild type- (WT-) CFTR, 9-AC in-
duced a large voltage-independent enhancement and a voltage-dependent inhi-
bition in the whole-cell (WC) current. 1-AC induced a smaller enhancement
and a larger voltage-dependent block in WT-CFTR WC currents in compared
with 9-AC. In the other hand, both 9-AC and 1-AC induced only a weak volt-
age-dependent inhibitions in genistein-potentiated G551D-CFTR WC currents
whereas, in curcumin-potentiated G551D-CFTR WC currents, 9-AC and 1-AC
induced similar effects to those in WT-CFTR. These suggest that curcumin and
genistein potentiated G551D-CFTR via different mechanisms. We speculate
that genistein-potentiated and curcumin-potentiated G551D-CFTRs might
have different protein conformations.
1671-Pos
Optimization of the NBD1 Site Improves the Function of G551D-CFTR
Channels
Ming-Feng Tsai, Kangyang Jih, Min Li, Tzyh-Chang Hwang.
Missouri University, Columbia, MO, USA.
CFTR chloride channels comprise two nucleotide binding domains (NBD1 and
NBD2).Mutations (for example,G551D) that impairCFTR function result in the
lethal genetic disease cystic fibrosis (CF). It’s established that the opening and
closing of CFTR are mainly controlled by ATP binding and hydrolysis respec-
tively in NBD2 while ATP binding at NBD1 can modulate the stability of the
open state. Using a non-hydrolytic ligand MgPPi, we locked open CFTR chan-
nels with mutations at NBD1. We found that two W401 mutations significantly
increased the lock-open time (W401F: 7253s; W401Y: 5156s; WT: 2752s).
These gain-of-function mutations are unexpected since the W401-equivalent
residue Y1219 in NBD2 can be effectively replaced by tryptophan but not phe-
nylalanine. As the ATP molecule bound in NBD1 may interact with NBD2’s
signature sequence (LSHGH), we extended our study to this region. We found
that reverting the histidine residue 1348 to the canonical glycine (H1348G) sim-
ilarly stabilized the lock-open state (t=6758s). Once W401F, H1348G, or
W401F/H1348G mutations were incorporated into G551D channels which no
longer respond to ATP, the mutant channels becomeATP-responsive with basal
activity increased by ~10-fold for W401F/G551D-, ~4-fold for H1348G/
5G551D-, and ~25-fold for W401F/H1348G/G551D-channels. The increased
